From Established Clinical Care to Emerging Models of Recovery and Well-being

Hyperbaric Oxygen Therapy: From Established Clinical Care to Emerging Models of Recovery and Well-being

Hyperbaric Oxygen Therapy (HBOT) has been part of modern medicine for decades, particularly in diving medicine, emergency care and complex wound management. Today, however, interest in hyperbaric technology is expanding beyond its traditional clinical environment.

Healthcare providers, sports organisations, wellness operators and investors are increasingly exploring how hyperbaric systems might fit within broader models of recovery, performance and healthy ageing. This creates an important opportunity, but also a responsibility to maintain a clear distinction between established clinical practice, emerging research and non-clinical wellness applications.

From pressure and oxygen to clinical effect
HBOT combines increased environmental pressure with oxygen administration. In medical-grade HBOT, treatment is typically delivered at pressures around 2.0–2.5 atmospheres absolute (ATA). As pressure increases, more oxygen dissolves directly into plasma, supplementing the oxygen transported by haemoglobin.

This oxygen-rich plasma can reach compromised and hypoxic tissues and influence physiological processes including angiogenic and inflammatory signalling and oedema reduction. The underlying physical principle is well established: according to Henry's Law, the amount of oxygen dissolved in plasma increases as barometric pressure rises.
These mechanisms provide the physiological foundation for the established clinical applications of HBOT. 

An established therapy with evolving areas of research
Recognised applications of HBOT include decompression sickness, arterial gas embolism and severe carbon monoxide poisoning. It is also used as an adjunct to standard care in selected wound and tissue-healing conditions, including selected diabetic foot ulcers, delayed radiation tissue injury and compromised grafts and flaps.
Other established applications include necrotising soft-tissue infections, refractory chronic osteomyelitis and gas gangrene. Importantly, HBOT generally functions as an adjunctive treatment, supporting rather than replacing appropriate standard-of-care therapies. Specific indications and commissioning arrangements vary between jurisdictions. 

Alongside these established uses, research is examining HBOT in areas related to cellular ageing, brain function and physical recovery. A prospective study published in Aging in 2020, for example, reported changes in telomere length and senescent cell populations following a specific HBOT protocol.¹ A separate randomised controlled trial in healthy older adults reported improvements in several cognitive measures alongside changes in cerebral blood flow.² 

These findings are scientifically interesting, particularly as interest grows in regenerative medicine and healthy ageing. However, they should not be interpreted as evidence that HBOT extends human lifespan. The emerging applications of HBOT require further independent investigation, appropriate patient selection and rigorous clinical evaluation.

Recovery, performance and well-being
Interest is also increasing in the potential role of HBOT in sports recovery. A recent systematic review and meta-analysis incorporating 10 studies and 299 participants reported that HBOT was associated with improved recovery from exercise-induced muscle injury, although it did not improve exercise-induced muscle soreness.³ 

At the same time, hyperbaric technology is appearing in non-clinical environments focused on recovery and general well-being. This expansion creates an important boundary for providers: commercial wellness services should remain clearly differentiated from medical treatment.

Not every hyperbaric system is equivalent. Medical-grade HBOT systems typically operate at higher therapeutic pressures and require appropriate oxygen delivery, pressure-vessel engineering, environmental monitoring and safety controls. Lower-pressure systems occupy a different operational space and should not simply be presented as equivalent to established medical HBOT. This distinction between different technologies and intended uses is fundamental to responsible service development. 

From purchasing a chamber to building a service
Perhaps the most important change in the sector is that hyperbaric technology is no longer confined to traditional hospital units. Outpatient facilities, sports-performance environments and wellness services are exploring different models of delivery, while specialised areas such as veterinary hyperbaric applications are also emerging. 

For organisations entering this field, however, purchasing a chamber is only one part of the project.

A safe and sustainable hyperbaric service starts with defining its intended use and assessing feasibility. This is followed by regulatory and standards assessment, equipment selection, site preparation, installation and systems integration. Before operation begins, staff training, competency frameworks, standard operating procedures and emergency response arrangements must also be established. Preventive maintenance and ongoing technical support then become part of the operational lifecycle. 

In the UK, applicable requirements depend on factors including the intended use, service model, equipment and regulated activities provided. Engineering safety, pressure-system requirements and appropriate clinical or operational governance therefore need to be considered from the beginning rather than added at the end of a project. 

This is where a turnkey approach becomes valuable: bringing clinical, engineering, regulatory and commercial planning together from initial concept through to safe operation.

Looking ahead
HBOT now sits at an interesting intersection between established medicine and emerging models of healthcare, recovery and well-being.

Its established applications are supported by decades of clinical use, while research continues to investigate new biological and therapeutic possibilities. At the same time, increasing interest in recovery, performance and healthy ageing is creating new environments for hyperbaric technology.

Sustainable growth in this field will depend on maintaining clinical integrity, operational safety and a clear distinction between established evidence and emerging applications.
For healthcare leaders considering hyperbaric services, the question is therefore no longer simply, “Which chamber should we buy?"

The more important question is: “What kind of hyperbaric service are we trying to build and how do we build it safely, responsibly and sustainably?”

References
1. Hachmo Y, Hadanny A, Abu Hamed R, et al. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging (Albany NY). 2020;12(22):22445–22456. doi:10.18632/aging.202188. 

2. Hadanny A, Daniel-Kotovsky M, Suzin G, et al. Cognitive enhancement of healthy older adults using hyperbaric oxygen: a randomized controlled trial. Aging (Albany NY). 2020;12(13):13740–13761. doi:10.18632/aging.103571. 

3. Luo X, Yu Y, Zhang S, Qi F. Effects of Hyperbaric Oxygen Therapy on Exercise-Induced Muscle Injury and Soreness: A Systematic Review and Meta-analysis. Archives of Physical Medicine and Rehabilitation. 2026;107(3):522–532. doi:10.1016/j.apmr.2025.07.017.